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 PENYESUAIAN METABOLIK CANDIDA ALBICANS BIOFILM 
 
 
 
    ABSTRAK 
 
Biofilm kulat mempunyai kepentingan klinikal yang tinggi. Salah satu yang 
ketara adalah biofilm Candida albican yang berupaya untuk memulakan jangkitan 
baru atau jangkitan semula kira-kira 40% daripada jangkitan kandidiasis yang 
disebarkan. Ciri utama biofilm yang membezakannya daripada sel –sel plankton 
adalah toleransi yang tinggi terhadap rawatan serta sistem imun. Laporan 
menunujukkan bahawa pertumbuhan sesil oleh sel bebas terapung mempunyai daya 
ketahanan beberapa kali ganda terhadap ujian nilai perencatan minimum atau MIC. 
Daya ketahanan yang tinggi itu adalah disebabkan oleh cir-ciri yang terdapat pada C. 
albican termasuk pengumpulan bahan extrapolymericn (EPS), penyesuaian fenotip 
serta fleksibiliti metabolic dan lain-lain.  Secara amnya, kajian ini melibatkan ujian 
ke atas peranan fisiologi metabolisme terutamanya laluan enzim glyoxylate isocitrate 
lyase atau ICL ke atas pembentukan biofilm, daya ketahanan, morfologi, dan 
komponen dinding sel. Keputusan yang menarik telah diperolehi yang mana biofilm 
yang terbentuk daripada strain mutasi ICL1 heterozigot dan homozigus menunjukkan 
tahap toleransi yang sama tinggi dengan strain kawalan (reference strain). Sifat 
enzim ICL dimorphism telah terjejas sebagaimana yang berlaku dalam strain mutasi. 
Keupayaan pemencilan oleh beta-1,3-glucan yang merupakan komponen utama 
karbohidrat dalam extracellular matrix atau ECM tidak menunjukkan sebarang tindak 
kesan balas. Penyingkiran enzim memberi kesan terhadap transkripsi protin dalam 
FKS1, ERG11 dan CDR2. FKS1 dan ERG11 telah menunjukkan peningkatan di 
setiap peringkat pertumbuhan manakala CDR2 telah menunjukkan peningkatan pada 
fasa awal pertumbuhan. Akan tetapi, ekspresi  telah menurun berbanding strain 
xvii 
 
kawalan. Oleh itu, laluan glyoxylate tidak boleh bertindak sebagai penentu 
kerintangan biofilm tetapi perlu untuk hidup. Kajian ini dapat dijadikan asas untuk 
mengkaji interaksi secara tunggal atau sinergi ke atas ubat yang berpotensi sebagai 
antikulat.  
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METABOLIC ADAPTATION OF CANDIDA ALBICANS BIOFILMS 
 
ABSTRACT 
Fungal biofilms have high clinical importance. A notable one is           
Candida albicans biofilm, whose importance is attributed to its ability to institute 
new and reoccurring infections, accounting for about 40% of disseminated 
candidiasis. The major characteristic of biofilms which differentiates it from 
planktonic cells is its high tolerance to treatments and the immune system. Sessile 
growths have been reported to be several folds resistant to the minimum inhibitory 
concentration (MIC) of free floating cells drug treatment, and consequently 
frustrating the efficacy of drugs. The high resistivity is attributed to distinctive 
properties including accumulation of extrapolymeric substance (EPS), phenotypic 
adaptation switch and metabolic flexibility among others. In this study, the 
influential roles of metabolism physiology, particularly glyoxylate pathway Isocitrate 
lyase (ICL) enzyme on biofilm formation, resistivity, morphology, and cell wall 
components were evaluated. It was interesting to find that, heterozygous and 
homozygous ICL1 mutant strains formed biofilm and exhibited a high tolerance level 
similar to the reference strain. The enzyme ICL impaired dimorphism trait as 
observed in mutant strains. Furthermore, sequestrating ability of beta-1, 3-glucan, a 
major carbohydrate component of the extracellular matrix (ECM) was not impaired. 
Deletion of ICL conferred a considerable effect on glucan synthase pathway FKS1, 
gene encoding 14-α-demethylase enzyme necessary for lanosterol conversion to 
ergosterol ERG11 and efflux pump gene CDR2 transcription. FKS1 and ERG11 were 
up regulated throughout the developmental stages; CDR2 was up regulated at the 
early phase. However, expression was down regulated compared to the reference 
xix 
 
strain. Therefore, Glyoxylate pathway is not a specific determinant of biofilm 
resistivity, but essential for its survival. This study serves as a foundation for future 
experimental investigation of sole and synergistic alternative pathways interactions 
for potential drug targets.  
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    CHAPTER 1 INTRODUCTION 
 
Fungal pathogens have gained wide attention in the last century due to high 
rate of infections caused by them (Calderone, 2002). Infection happens 
predominantly in immunocompromised individuals with lower cluster of CD4 
lymphocyte count, cancer and surgical patients (Jabra-Rick et al., 2004). C. albicans 
is a major systemic and most commonly isolated fungal pathogen, accounting for 
about 80% of clinical fungal infections (Douglas, 2002). In spite of advancement in 
the management of hospital acquired infections, C. albicans infections rank fourth 
most commonly isolated nosocomial blood stream pathogen (Ramage et al., 2005; 
Douglas, 2002; Pfaller et al., 1998).  Fungal infections fatality rate is about 40%, 
with C. albicans responsible for about 80-90% of cases (Sardi et al., 2013; Ramage 
et al., 2012; Brown et al., 2007).  Microbes exist in nature mostly as attached 
aggregated communities (Ballie & Douglas, 2000). Biofilm is an irreversible 
assemblage and attachment of microorganisms on surfaces protected in a self 
secreted polymeric substance (Ramage et al., 2012; Ballie & Douglas, 2000). Human 
fungal pathogens including Candida species, Aspergillus and Cryptococcus produce 
biofilms and institute infections such as urinary tract infection (Finkel & Mitchell, 
2011; Douglas, 2003).  
A characteristic attribute of biofilm is resistance to antimicrobials controlled 
by multifactorial and interconnected factors. Implicated mechanisms includes β-1,3-
glucan, extracellular matrix (ECM), efflux pump mediated resistance, cell density, 
over expression of drug target genes and metabolism plasticity (Bink et al., 2012; 
Ramage et al., 2012; Al-fattani & Douglas, 2006). C. albicans is metabolically 
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flexible, i.e. the type of nutrient available determines the absorption pathway (Askew 
et al., 2009). The absence of fermentable carbon signals alternative pathways 
particularly β-oxidation, glyoxylate and gluconeogenesis cycles (Askew et al., 2009).  
1.1 Significance of Study 
The gene conferring resistance, ATP dependent transporters are highly 
expressed in planktonic cells and early phase of biofilm, thereby decreasing 
susceptibility (Murkejee et al., 2003). However, their absentia function in mature 
biofilm resistance shows that other molecular mechanisms and genes are involved 
(Ramage et al., 2001). Expression of ERG11 when challenged with fluconazole may 
signal point mutation and increased copy of 14-α-sterol demethylase via upregulation 
of the encoding gene (Sanglard, 2002). Additionally studies have proposed that the 
utilization of alternative pathways may have an indirect role on biofilm resistance by 
providing hexoses which are monomer building blocks for synthesis of β-1,3-glucan 
in the matrix (Nett et al., 2009; Nobile et al., 2009).  Biofilm matrix comprises of β-
1, 3-glucan, which not only contribute to adhesion but also protects sessile cells from 
antifungal agents through drug sequestration (Nett et al., 2007). Experimental studies 
showed that glucan synthesis by glucan synthase is dependent on the expression of 
glucan synthase FKS1 gene. Production machinery is signalled when glucan 
concentration is low; in turn triggering glucan delivery enzymes to act and deliver 
glucan to the matrix in a controlled pathway (Taff et al., 2012; Nett et al., 2011; Nett 
et al., 2007 ). This study aims to further define the contribution of metabolism to 
Candida biofilm resistance, providing insight for development of drug targeting 
isocitrate lyase enzyme as a potential strategy for generating antifungal drugs 
effective against Candida biofilm infections. 
3 
 
1.2 Study Objective 
 High resistance exhibition is a peculiar trait of biofilms. C. albicans like 
bacterial biofilms is 1000X tolerant to treatment therapy unlike their free floating 
cells (Ballie & Douglas, 2000). Metabolic flexibility is an attribute extensively 
explored for survival, allowing for the use of fermentable and non- fermentable 
carbon sources. Glyoxylate pathway is an anabolic cycle that converts acetyl-CoA to 
succinate and malate for the synthesis of carbohydrates though gluconeogenesis 
cycle. It is the most preferred nutrient absorption route because the process is faster 
through decarboxylation step bypass and lower energy consumption compared to 
TCA pathway (Lorenz et al., 2004).  
Thus, a question arises whether their biofilm exploit other range of carbon 
when glucose is absent, and if the alternative carbons have significant role as 
contributing factor to their high tolerance of antifungal therapy in humans. 
Relatively, H2O soluble polysaccharide β-1, 3 -glucan is a major component of the 
extracellular matrix suggested to contribute to resistivity of biofilms. Glucan 
concentration at each formation phase were quantified and correlated to energy 
synthesis to examine if absence of glyoxylate affects hexoses buildup. 
  To further ascertain the role of glyoxylate pathway in biofilm formation and 
antifungal drug resistance, ability of heterozygous and homozygous knockout strains 
of C. albicans (CaICL1/icl1 and Caicl1/icl1) lacking ICL to form biofilm and build 
resistance to antifungal agents was studied. In addition to observe if a correlation 
exist between cell carbohydrates and matrix glucan concentration during the 
developmental stages. Transcriptional regulation of biofilm associated genes for the 
mutant strains were also studied under biofilm-forming conditions.  
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Specific objectives of study; 
i. To study the functional role of Candida albicans glyoxylate ICL enzyme by 
comparing the ability of constructed heterozygous knockout (CaICL1/icl1), 
homozygous knockout (Caicl1/icl1) and wildtype strains to form biofilm and express 
their resistance phenotype.  
          
ii. To examine single, double knockout and the wildtype strains cell wall and the 
ECM properties; specifically hexoses and glucan synthesis.  
          
 iii. To study transcriptional regulation of biofilm resistance associated genes FKS1, 
ERG11, and CDR2 in the strains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
CHAPTER 2 LITERATURE REVIEW 
 
2.1 Candida albicans Infections  
C. albicans and related species; Candida glabrata, Candida tropicalis, 
Candida krusei and Candida parapillosis are commensal organisms, residing as 
benign flora of niches including the gastrointestinal tract, buccal cavity, vagina and 
mucosal surfaces of the body. They make up about 50% of microbiota population in 
humans (Odds, 1988). C. albicans is a unicellular oval shaped diploid fungus that 
grows as yeast cell and filamentous hyphae (Ramage et al., 2012; Bendel et al., 
2003; Douglas, 2002).  The proliferation and the increasing frequency of pathogenic 
opportunistic Candida infections are to a certain extent favoured by the use of 
antibiotics, use of oral contraceptives, poor oral hygiene and hormonal imbalance, 
which offsets population normalcy balance (Ruhnke, 2006; Douglas, 2002). About 
50% of women aged over 25 years experience vulvovaginal candidiasis once or more 
in their life time. Moreover, food with high starch level may contribute to chronic 
infections (Ciara & Dorothy, 2005). Being an opportunist pathogen, risk factors 
influencing superficial, disseminated and invasive candidiasis have been identified. 
These factors include immunosuppression, low birth weight, broad spectrum 
antibiotics, parenteral nutrition, and haemolysis among others (Calderone & Clancy, 
2012; Pappas et al., 2004). Infections caused by C. albicans can be superficial or 
invasive. Invasive candidasis is predominantly endogenous in origin, but 
transmission from person to person can also occur; known as exogenous transmission 
(Pfaller, 1996), occurring mostly in stem cell and liver transplant, and intensive care 
patients.  
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Trans-establishment can be exogenous through health care professionals and 
contaminated health care materials, and endogenous transmission is encouraged by 
weak immune system (Pfaller, 1996). This gives rise to colonization opportunities to 
inhabitants (Soll, 2001; Cole et al., 1996), and thus causing oropharyngeal 
candidiasis: characterized by white patches on the mucosa surface of the mouth; 
colonization of the respiratory tracts due to haematogenous spread of colonies 
content of oropharyngeal origin; diaper rush in kids; burning and itching of the 
inflammatory region in women, nail and skin folds (Colombo & Guimaraes, 2003; 
Ruhnke, 2002).  
Chronic mucocutaneous candidiasis is an important superficial Candida 
infections involving colonization of both mucosal and skin surfaces by Candida 
species (Bhowate & Dubey, 2004). It develops mostly in patients with impaired       
T-cell function, causing poor cell mediated immunity, characterized by continual 
candidal infection of skin, scalp and nails, (Bhowate & Dubey, 2004; De Moraes-
Vasconcelos D et al., 2001). Disseminated or systemic candidiasis is a bloodstream 
infection also known as candidemia. It occurs as a result of breakage in the epithelial 
tissues mostly in immuocompromised individuals. It encompasses myocarditis, 
hepatosplenic abscesses and central nervous system (CNS) infections, with 
possibility of leading to death. Also, HIV patients suffered from oral thrush before 
the advent of the HAART (Highly Active Anti-retroviral Treatment) therapy, which 
includes a protease inhibitor that also inhibits an important virulence attribute of     
C. albicans secreted aspartyl protease (Munro & Hube, 2002).  
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 2.2 Treatment Therapy 
The choice of treatment of fungal infections depends on the immunological 
status of patient, the site of infection, type of infection, and infecting Candida 
organism (Pappas et al., 2004). The most commonly used clinically approved 
antifungal drugs include the azoles (ketoconazole, voriconazole, fluconazole), 
polyenes (amphotericin B) and echinocandins (micafungin, caspofungin and 
anidulafungin) (Pappas et al., 2004).  Combination of drugs is mostly encouraged to 
fight drug resistance which develops during treatment process (Shinde et al., 2012). 
Polyenes; particularly amphotericin B, is commonly used in combination with 
flucytosine, because C. albicans can develop tolerance when treated with flucytosine 
alone (Shinde et al., 2012). Until 1950s, amphotericin B was the standard for 
treatment, typically used to treat systemic infections due to its high fungicidal 
activity, and mostly administered intravenously (Brajtbutg et al., 1990). 
Amphotericin B increases cell wall permeability by binding to ergosterol, and in turn 
limits the function of the ergosterol (Brajtbutg et al., 1990). It is however unfortunate 
that the clinical utility of amphotericin B is restricted because it causes 
nephrotoxicity and hypokalemia in patients (Deray, 2002; Ghannoum & Rice, 1999). 
Meanwhile, resistance has also been reported in some species, although in a less 
frequent way (Ellis, 2002). Furthermore, the adverse effect of the drug has reduced 
due to the development of lipid formulations, but not eliminated (ABLC, ABCD,     
L- Amp) (Odds et al., 2003). Azoles are mostly utilized as frontline defence and 
treatment, due to its bioavailability, water solubility and true fungistatic activity with 
fewer side effects. It can be administered orally and intravenously (Nailis et al., 
2010). Fluconazole halts sterol biosynthesis, by binding to 14-α demethylase enzyme 
encoded by ERG11, thereby obstructing lanosterol conversion to ergosterol causing 
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buildup of toxic sterol intermediates (Ghannoum & Rice, 1999). However, long term 
usage results in development of resistance as reportedly seen in C. albicans (Nailis et 
al., 2010; Sanglard & Odds, 2002; Franz et al., 1998).  
Voriconazole has a broader spectrum activity than fluconazole (Hazen et al., 
2003). It exhibits significant clinical efficacy against acute invasive aspergillosis and 
fluconazole resistant infections (Hazen et al., 2003). However, a drawback of 
voriconazole is late oral administration, typically after intravenous application for 
dose maintenance in the blood (Hazen et al., 2003). Also, miconazole is an effective 
therapeutic broad spectrum that exerts fungistatic activity on wide range of Candida 
species and dermatophytes, enhanced by reactive oxygen species (ROS) production 
and by hydrogen peroxide degrading enzymes inhibition: for example peroxidase and 
catalase (Vandernbosch et al., 2010). The availability of ROS increases susceptibility 
of cells and potency of the drug (Francois et al., 2006; Sreedhara Swamy et al., 
1974). The advent of echinocandins notably caspofungin, was a major advancement 
in fungal infection treatment. It is water soluble and constitutes prophylactic and 
fungicidal actions against fungal infections (Shao et al., 2007). It is the only class of 
fungal cell wall inhibitors approved for clinical use (Shao et al., 2007), and currently 
used for the treatment of invasive candidiasis. Casopfungin targets the β- 1, 3- glucan 
synthesis (Odd et al., 2003). However, echinocandins agents have been associated 
with liver toxicity (Hoehamer et al., 2010). Despite therapeutic treatment 
developments, C. albicans has became tolerant through phenotypic variations; 
forming complexes identified as biofilms, which prevent the diffusion of the drugs 
into the microenvironment; also by shielding and protecting the cells from the 
fungicidal behaviour of the antimicrobials (Walker et al., 2008; Ramage et al., 2005). 
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2.3 Virulence Traits of C. albicans 
Understanding the virulence factors associated with Candida infection is 
paramount to knowing the mechanisms used by C albicans to cause infections, to 
avoid the immune system and exhibit resistance to drugs. C. albicans has extensive 
mechanisms facilitating its successful invasion, evasion, disease progression and 
establishment leading to clinical problems (Kim & Sudbery, 2011; Calderone & 
Fonzi, 2001). Infection establishment by Candida treads a pattern proceeding with 
adherence to surfaces, replication of cells, production and accumulation of hydrolytic 
enzymes that damage tissues, and penetration of epithelial surfaces (Calderone, 
2002; Coller & Kavanagh, 2000). These virulence attributes aids it pathogenicity, 
underlay its transition from commensal resident to opportunistic pathogen (Kim & 
Sudbery, 2011). Candida species colonizes and cause disease at distinct sites with 
unique physiological environment (Calderone & Fonzi, 2001). It also disrupts certain 
properties possessed by the potential host, which may promote the manifestation of 
disease through imbalance of physiological processes and homeostasis        
(Calderone, 2002). Oral candidiasis is encouraged by hypoxia which in turn activates 
the expression of stress adaptation genes (Yun- Liang Yang, 2003). These include 
morphogenesis, secretion of hydrolytic enzymes, and expression of adhesin 
molecules phenotypic switching and biofilm formation (Naglik et al., 2004; 
Calderone, 2002). 
2.3.1  Adhesins and Invasins 
Adherence of C. albicans to surfaces is an essential step for successful 
colonization (Coller & Kavanagh, 2000). Adherence is mediated by ligand 
receptor interactions, electrostatic charges and chemical bonds (Coller & 
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Kavanagh, 2000).  Expressed cell wall molecules such as invasins and 
adhesins often seen as extracellular proteins on host cells promote C. albicans 
pathogenicity by enabling its attachment and proliferation, (Calderone & 
Braun, 1991). Agglutinin-like sequences (ALS) family genes encode glycosyl 
phosphatidylinositols (GPI) surface protein known to facilitate fusion to host 
cells epithelial and endoepithelial surfaces (Liu & Filler, 2011). Als3 is the 
most well characterized protein from ALS family multifunctional proteins, 
acting as an adhesin and invasin.  Als3 mediates host cell damage and uptake 
of C. albicans through active penetration and endocytosis (Liu & Filler, 2011; 
Wachler et al., 2011; Hoyer et al., 2008). Active penetration often requires 
viable hyphae for successful penetration, through yet to be elucidated 
mechanisms, unlike endocytosis invasion that requires either through dead or 
living hypahe, influenced by Als3 and Ssa1 through clathrin dependent 
process (Wachler et al., 2011; Phan et al., 2007). They express different 
phenotypic features during infection depending on environment’s 
susceptibility to invasion and progression (Liu & Filler, 2011; Hoyer, et al., 
2008). 
Hwp1, a hyphae specific surface glycoprotein, is another relevant 
adhesin which links hyphae to the host cell though transglutaminases-
mediated mechanisms (Sundstrom, 1999). Other proteins have been implied 
to exert indirect function on adhesion such as MNT1 and PMT1 
mannosyltransferases for cell wall synthesis of mannan (Martinez-Lopez      
et al., 2006). 
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2.3.2  Morphogenesis 
Polymorphism trait refers to morphological changes in the cell shape. 
Majorly unicellular yeast cells, filamentous growth forms, and the 
pseudohyphae (Whiteway & Bachewich, 2007; Saville et al., 2003). The 
transformation of yeast cell into hyphae is an adaptation mechanism to 
environmental stress (Whiteway & Bachewich, 2007; Casadevall & Pirofski, 
2003). Its dissemination into the bloodstream is favoured by yeast form of 
growth for easy dispersal (Han et al., 2011). It metamorphosis to hyphae 
serves as an escape route from the immune system; because the phagocytes 
may find it difficult to abolish high population of filaments fused on infected 
tissues (Jayatilake et al., 2006; Calderone & Fonzi, 2001).When engulfed by 
phagocytes, they grow in filaments, thereby penetrating the wall of the 
phagocytic cell and killing the cell in the escape process (Jayatilake et al., 
2006; Calderone & Fonzi, 2001). 
A range of acknowledged features induces morphological transition in 
C. albicans (Mayer et al., 2013). For example, high alkaline pH medium and 
temperature ˃370C promotes hyphae development; likewise, presence of N-
acetylglucosamine, CO2, nitrogen starvation, and glucose and muramyl 
dipeptides induces filamentous forms (Mayer et al., 2013; Sudbery, 2011; Xu 
et al., 2008). Molecules mediating cell to cell communications (QSMs) 
regulate morphogenesis, in correlation with the cell density; tyrosol activates 
yeast filamentous growth at low cell density (Han et al., 2011). Interestingly, 
hyphae morphogenesis influence non associated hyphae virulence factors 
such as adhesions and hydrolytic enzymes (Han et al., 2011).  
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2.3.3  Hydrolytic Enzymes 
Of importance is proteinases, secreted aspartyl proteases (SAP) and 
phospholipases contributing to virulence through digestion of the host cell 
membrane proteins, lipids and surface molecules for invasion and 
extracellular proteolytic activity (Silva et al., 2011; Naglik et al., 2003). 
Secreted aspartyl proteases (SAP) family comprises of 10 members (Albrecht 
et al., 2006). Meanwhile, SAP1 have been reported to be indispensable for 
virulence through exertion of damage to the reconstituted human epithelium 
(RHE) (Naglik et al., 2003).  PLB (PLB1-5) are part of phospholipases (PL) 
family of four members, classified based on specific ester bond cleavage 
during hydrolysis of glycerophospholipids (Silva et al., 2011; Theiss et al., 
2006). They contribute to host cell membrane disruption and degradation 
during invasion (Silva et al., 2011; Theiss et al., 2006). Extracellular 
enzymes lipases (LI) comprises of 10 members (LIP1-10) (Leidich et al., 
1998). They exert lipolytic properties by enabling digestion of fatty acids as 
carbon source (Hube et al., 2000). Also, the enzymes interact synergistically 
with other enzymes and proteins to promote adhesion, penetration and attack 
on the immune system (Gacser et al., 2007).  
2.3.4  Phenotypic Switching  
Phenotypic switching is a reversible high frequency of white opaque 
transition (Huang, 2012). It is a process of cellular morphological change, 
antigenic variation and tissue affinity; distinguishable by colony morphology, 
virulence, metabolism, mating ability and specific gene expression (Huang, 
2012; Slutsky et al., 1987). Transition is mediated by mating type like (MTL) 
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locus, which is also responsible for sexual replication process, through 
homozygous a and α loci complexes (Miller & Johnson, 2002). Homozygous 
complexes enable switching and vice versa (Zordan et al., 2006; Miller & 
Johnson, 2002). White cells are more virulent, mediating colonization and   
immune system scrutiny escape (Porman et al., 2012). Most strains of          
C. albicans strains isolated from patients with vaginitis displayed relatively 
spontaneous high frequencies of phenotypic switching suggesting a role for 
switching in virulence (Calderone & Fonzi, 2001). WO-1 phenotype is the 
best studied switching type, reflected by cell shape, colour, ability to form 
hyphae and carbon requirement characteristics (Sahni et al., 2009).  
Switching of cells plays a vital role in establishment of invasive infections 
(Lan et al., 2002). Opaque cells requires alternative assimilation processes, 
which may improve it virulence in superficial infections (Huang, 2012), 
while white cells preference for glucose facilitates and maintains disease 
development in systemic infections (Lan et al., 2002). Furthermore, a 
suggested correlation with metabolism reinstates the fact that adaptation to 
various niches is ensured through variety of mechanisms (Lan et al., 2002; 
Miller & Johnson, 2002; Kvaal et al., 1999).   
2.3.5 Stress Responses 
Environmental stress responses are adaptive processes that contribute 
to C. albicans survival in the environment. They do so by conferring 
protection in opposition to host induced stresses (Enjalbert et al., 2003). Most 
studied stresses are oxidative, heat shock and osmotic stress and nutrient 
depletion. Depending on the environmental signals, genes involved in stress 
responses are differentially expressed to meet the need for successful 
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infection establishment (Brown et al., 2012). These signals include 
nitrosative stress, osmotic stress, oxidative stress, low and high temperature 
(Brown et al., 2012). During phagocytosis, C. albicans counteract nitrosative 
stress caused by RNS and nitric oxide (NO) exerted though the engulfing 
phagocyte by upregulating Yhb1 flavohemolyglobin protein, that detoxifies 
NO and RNS. Deletion of YHB1 gene in C. albicans slows evasion. This may 
be due to its ability to encourage and promote yeast to hyphal growth 
(Hromatka et al., 2005). During osmotic stress, the cell is signalled through 
MAPK (mitogen activated protein kinase pathway) activated by Hog1 protein 
kinase, to develop counter reactions (Monge et al., 2006; Smith et al., 2004). 
MAPK pathway is also involved in other cellular processes including 
morphogenesis, cell wall formation, respiratory mechanisms and stress 
responses (Smith et al., 2004).  Osmotic stress is opposed by increased 
expression of glycerol biosynthesis enzymes GPD2 (glycerol-3-phosphate 
dehydrogenase), and GPP1 (glycerol-3-phosphatase) for glycerol 
accumulation. A response regulated by Hog1 transcription factor (Mayer et 
al., 2013; Enjabert et al., 2003). 
Oxidative stress response is activated when cells are exposed to 
abnormal intensity of yeast generated ROS through usual metabolic processes 
or environment oxidants such as hydrogen peroxide (H2O2), potassium 
superoxide (KO2) and hydroxyl radicals (OH
-
) and neutrophils hypocholorous 
acid. Thus, initiating DNA, proteins, and lipids degradation that leads to cell 
lysis (Tosello et al., 2007). C. albicans uses the activity of antioxidant 
detoxifying enzymes particularly, superoxide dimutases (SODS), 
glutaredoxins (GRXS), thioredoxim (TRX) and catalases (CAT), regulated by 
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Cap1 transcription factor (Tosello et al., 2007; Enjalbert et al., 2006; Alonso-
Monge et al., 2003; Estruch, 2000). 
Heat shock stress (HSS) results from contact with environmental 
stressors such as toxins, nutrient starvation, hypoxia, nitrogen deficiency and 
high temperature (Burnie et al., 2006). These stressors triggers heat shock 
proteins (Hsps) and small heat shock proteins (sHsps), a process regulated by 
evolutionary conserved heat shock transcription factor (Hsf1) through 
binding of specific sequences in their promoters (heat shock elements, HSE). 
They prevent protein aggregation, denaturation and unfolding (Sorger & 
Pelham, 1987).  In addition, elevated level of Hsps may help morphological 
shift to hyphae development, a phenomenon common with stress in              
C. albicans. Eleven essential Hsps are reported to be associated with HSS 
response in C. albicans (Nicholls et al., 2009). They have been illustrated to 
affect antifungal drug resistance particularly Hsp70 and Hsp90. Hsp21 is 
important to maintain trehalose intracellular levels (Nicholls et al., 2009). 
Furthermore, Hsp90, an invasin protein that plays a role during HSS has been 
shown to induce biofilm formation and resistance (Robbins et al., 2011). 
2.3.6  Biofilm Formation 
Another major virulence factor that also relates to the background of 
this study is biofilm formation. Candida species possess the ability to attach 
to host tissues and medical device surfaces, attracting and replicating more 
cells, building up extracellular matrix (ECM) that protects the community 
from immune attack and antifungal agents (Chandra et al., 2008). It thereafter 
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disperses to invade the blood stream and cause infection (Chandra et al., 
2008; Pierce et al., 2008; Hawser & Douglas, 1994). 
2.4  Metabolism 
2.4.1  Cell Carbon Metabolism  
C. albicans is a facultative anaerobe capable of carbon assimilation through 
cellular respiration and fermentation, contrasting its homologue S. cerevisiae that is 
solely dependent on fermentation (Lorenz et al., 2004). Maintenance of cellular 
reactions involves biochemical reactions that permit the breakdown of molecules for 
cell growth (Karin & Ben, 2010). The uptake of 6 carbon compounds e.g. Glucose is 
through glycolytic pathway that takes place in the cytoplasm converting glucose 
molecules into pyruvate and energy in form of two adenosine triphosphate (ATP) 
and two nicotinamide adenine dinuclecotide (NADH) as shown in figure 2.1 (Askew 
et al., 2009). In the absence of fermentative carbon sources, C. albicans use non-
fermentative carbon sources through three paramount pathways namely glyoxylate, 
fatty acid β-oxidation and gluconeogenesis that favours virulence (Lorenz & Fink, 
2001).  
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Figure 2.1. Glycolysis and gluconeogenesis pathway. Glycolytic and 
gluconeogenesis cycles make energy available for life sustenance in microorganisms 
and higher living forms. ATP, NADH and pyruvate are the end product of 
carbohydrates, derived through catabolic glycolytic pathway. Glycolysis pathway is 
divided into three steps indicated by pink, yellow (irreversible reaction) and green 
areas. Gluconeogenesis is the reversible reaction of glycolysis. It synthesises glucose 
from non-carbohydrate sources such as glycerol, lactate oxaloacetate. Glucose-6-
phosphatase converts fructose-6-phosphate to glucose. Enzymes catalysing each step 
are written in blue and red, and the synthesized products marked in black. Adapted 
from Berg et al., (2002). 
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  Metabolic mechanism implored by C. albicans is dependent on the available 
nutrient in the environment (Barelle et al., 2006; Fradin et al., 2005; Garcia- Sanchez 
et al., 2005). Pathogens are metabolically dynamic, mediating their survival in 
diverse ecological niches, by imploring diauxic shift (Rodaki et al., 2009). Studies 
showed that 16 metabolic pathways involved in carbon catabolite metabolism (CCM) 
are significantly up-regulated during morphological change to filamentous growth, 
stimulated by nutritional stress in order to maintain cellular functions (Han et al., 
2011). When engulfed by macrophages, they make rapid shift from preferred to 
available non-preferred carbon sources (Prigneau et al., 2003). They assimilate 
available carbon sources through anabolic pathways (Prigneau et al., 2003). Studies 
have also shown that during early phase of infection and phagocytosis, glycolytic 
genes are down regulated and alternative pathways:  glyoxylate, β-oxidation; amino 
acid biosynthesis genes are over expressed (Rubin- Bejerano et al., 2003; Lorenz & 
Fink, 2001). This was confirmed by northern blotting showing the repression of 
M1g1 regulator, a glycolytic transcriptional regulator, hyphal and alternative 
pathway repressor (Gurvitz et al., 2006).  
2.4.2 Gluconeogenesis  
Gluconeogenesis pathway is an intermediate cycle for generating 
hexoses from non carbohydrate molecules for glycolysis (Barelle et al., 2006; 
Lorenz et al., 2004). Deletion of PCK1 gene confers a significant virulence 
decrease in mouse model of systemic infection (Fradin et al., 2005). 
Phosphoenolpyruvate is condensed by phosphoenolpyruvate carboxylkinase 
enzyme (PCK); the reaction continues until fructose-1, 6-biphosphate is 
converted to glucose.  
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2.4.3  Βeta Oxidation Pathway 
This pathway mediates the synthesis of acetyl CoA from fatty acids, a 
reaction localized to the mitochondria and peroxisome (Perkarska et al., 
2006). Fatty acids are transported by carnitine acetyltransferase enzymes 
(Hiltunen et al., 2003). It is an adaptation pathway essential for survival in 
hostile environments (Lorenz et al., 2004). Upon macrophage engulfment, 
metabolism is switched to permit lipid utilization, signalled by expression of 
FOX2 enzyme (Lorenz et al., 2004). Recently, it was reported not to be fully 
significant for virulence as shown in a FOX2 mutant strain, which exhibited 
virulence capability (Piekarska et al., 2006; Lorenz et al., 2004). However, it 
may have a complimentary role in the virulence of C. albicans (Piekarska et 
al., 2006; Lorenz et al., 2004). Energy production is facilitated through 
metabolism of fatty compounds such as oleate to acetyl-CoA (C2), a 
precursor for the glyoxylate pathway for haemostasis maintenance and 
pathogenicity (Prigneau et al., 2003). Four catalytic enzymes involved are 
acyl CoA dehydrogenase, enoyl- CoA hydratase, 3-hydroxyl acyl CoA 
dehydrogenase and beta- ketoacyl-CoA thiolase (Prigneau et al., 2003). A 
process repeated until 2 carbon compound e.g. Acetyl- CoA is generated for 
glyoxylate and TCA cycle as shown in figure 2.2  (Strijbis & Distel, 2010). 
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Figure 2.2. Fatty acid βeta-oxidation. The cycle comprises of four distinct steps 
namely oxidation, hydration, oxidation and cleavage. The reacting enzymes are 
marked in blue. Adapted from Nelson and Cox, 2005. 
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2.4.4  Tricarboxylic acid (TCA) and Glyoxylate Pathway 
Tricarboxylic acid (TCA) pathway also known as citric acid cycle 
utilizes acetyl CoA synthesized from pyruvate and fatty acids, and 
oxaloacetate as a precursor substrate for citric acid synthesis, catalysed by 
citrate synthase enzyme (Soares- Silva et al., 2004). Glyoxylate cycle is a 
shunt of TCA. It utilizes non carbohydrate sources during phagocytosis and 
environmental stress, which provides the potential to generate glucose from 
two-carbon molecules, imperative for full virulence in C. albicans (Lorenz et 
al., 2004; Lorenz & Fink, 2001).  This pathway as shown in figure 2.3 is 
mediated by two major enzymes, namely isocitrate lyase (ICL) that catalyses 
isocitrate intermediate to glyoxylate, and malate synthase (MLS) which 
cleaves glyoxylate to malate, and subsequently converted to 
phosphoenolpyruvate (C4) (Barelle et al., 2004; Lorenz & Fink, 2001). 
Glyoxylate cycle is predicted to be vital pointer for nutrient deprivation.   
Earlier reports showed that deletion of ICL1 and MSL1 genes following 
macrophage engulfment increases it susceptibility to immune defences 
(Fradin et al., 2005; Lorenz & Fink, 2001).   
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Figure 2.3. Depiction of enzymatic steps in the TCA and glyoxylate cycle. 
Glyoxylate cycle is a shunt of TCA; shorter and less energy consuming by bypassing 
decarboxylation step. The oxaloacetate (C4) synthesized enters into the 
gluconeogenesis pathway. Specific steps and enzymes of glyoxylate cycle are shown 
in red. Adapted from (Lorenz & Fink, 2001).  
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Evidently, glucose availability represses transcriptional expression of        
non-preferred pathways encoding genes (Piekarska et al., 2008). Doblin et al. 2012 
study using quantitative reverse transcriptase real polymerase chain reaction       
(qRT-PCR), demonstrated that the pathogenic yeast can take in relevant 
concentrations of two carbon compounds such as oleate and glucose simultaneously. 
This property was credited to the lack of post translational regulation mechanism and 
ubiquitination. Apart from glyoxylate, gluconeogenic and β-oxidation pathways, 
little is known about other pathways that may be solely or synergistically involved. 
Another important thing is that despite the crucial role of alternative pathways for 
survival, glycolytic genes activation is necessary for disease progression. That is non 
preferred sources might be required for adaptation during immunity defence, but not 
for disease advancement, thereby affirming their collective role (Piekarska et al., 
2008). 
2.5  Microbial Biofilms   
Biofilms was first described in the 17
th
 century by Van Leeuwenhoek while 
examining a plague on a tooth surface. They create distinct growth from planktonic 
cell growth characterized by interwoven assemblage of cells (Douglas et al., 2003; 
Donlan & Costerton, 2002). Formation of biofilm can be described as a defence 
mechanism, and a collective effort to avoid and combat the immune cells. Living 
cells of different species of microorganisms form complex clumps, living in close 
proximity on biotic and abiotic hydrated surfaces, such as bypass grafts, ocular 
lenses etc., and disseminating to cause septicaemia (Douglas et al., 2008). These 
active cells changes from free floaters to stickers on surfaces through rapid change of 
adaptive phenotypes. They are often times irreversibly attached through the use of 
pili. In most clinical scenarios, biofilm causing diseases are predominately bacteria 
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and polymicrobial communities (Douglas, 2003). Recognition of specific and non 
specific attachment sites, nutritional cues, and exposure to antimicrobial stimulates 
organism’s response in the form of biofilm development (Finkel & Mitchell, 2011; 
Ballie & Douglas, 2000). High rate of urinary catheter and central line blood stream 
infections have close association with indwelling devices, including pacemakers. 
Urinary catheters now frequent with more than 10 million recipients each year, 
which encourages microbial biofilm growth (Taff et al., 2012).  
2.6  C. albicans Biofilm  
Fungal biofilms associated infections are becoming more prominent 
especially in immunosuppressed patients (Ghannoun & Rice, 1999). Unlike bacterial 
biofilm that has been intensively studied with considerable amount of information on 
their properties. However in recent years, more studies have focused on fungal 
biofilms to give insight about the complex developmental process as it have been 
implicated in substantial proportion of human infections (Nett et al., 2007; Ballie & 
Douglas, 2000). The most studied yeast pathogen is C. albicans. The etiologic cause 
of invasive candidiasis when defences are repressed (Lionakis & Netea, 2013).             
C. albicans is the most common yeast pathogen associated with implanted medical 
device implants such as central catheters, intracardiac prosthetic valves (Taff et al., 
2012). It causes life threatening conditions such as urinary tract infection, and 
endocarditis, with mortality rate as high as 30% (Finkel & Mitchell, 2011; Nett et al., 
2010). C. albicans biofilm studies are expected to generate data that will serve as a 
reference foundational background for other fungi. Several experimental and 
discovery studies have generated lots of information and working definitions for 
biofilm (Ramage et al., 2005; Hawser & Douglas, 1994).  
